Nurse Anesthetist - CR in Jefferson City, MO Accepting Medicare

28 Nurse Anesthetist - CR nurses found. Showing 21 - 28

Jordan Paul Taylor, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 2505 Mission Dr, Jefferson City, MO 65109 Phone: 573-636-3483    Fax: 573-636-3386

John David O'donnell, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1445 Christy Dr, Jefferson City, MO 65101 Phone: 573-636-3483    Fax: 573-636-5315

Dustin M. Ambler, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1445 Christy Dr, Jefferson City, MO 65101 Phone: 573-636-3483    Fax: 573-636-5315

Sara Bess Enochs, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 2505 Mission Dr, Jefferson City, MO 65109 Phone: 573-636-3483    Fax: 573-636-3386

Sandra A. Uhlmann, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1445 Christy Dr, Jefferson City, MO 65101 Phone: 573-636-3483    Fax: 573-636-5315

Jeffrey R. Brade, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1445 Christy Dr, Jefferson City, MO 65101 Phone: 573-636-7716    Fax: 573-636-5315

Bart Edward Horton, C.R.N.A. Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1125 Madison St, Jefferson City, MO 65101 Phone: 573-632-5357    Fax: 573-632-5841

Nathan P Meyer, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1125 Madison St, Jefferson City, MO 65101 Phone: 573-632-5357    Fax: 573-632-5841

News Archive

Now, women experiencing morning sickness can benefit from Diclegis drug

Up to 85 percent of pregnant women are affected by nausea and vomiting of pregnancy (NVP), more commonly known as morning sickness.

Combining two chemotherapy drugs with Herceptin shows promise for metastatic HER2+ breast cancer

At the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO), researchers from the Mayo Clinic campus in Florida report that using a combination of capecitabine, vinorelbine, and trastuzumab offers a treatment option that is at least as beneficial as other current options - and doesn't cause hair loss in patients.

Vitamin D Total assay for use on Access 2 and UniCel DxI immunoassay systems receives CE Mark

Beckman Coulter, Inc. announces the CE Mark approval of Access 25 (OH) Vitamin D Total assay for use on the Access 2 and UniCel DxI series of immunoassay systems. Offering enhanced performance, the new assay is an important addition to the company's bone metabolism assay menu.

USFDA approves Sun Pharma's generic Keppra Injection ANDA

Sun Pharma announced that USFDA has granted an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Keppra® Injection, levetiracetam injection.

Read more Medical News

› Verified 6 days ago

• 1
• 2(current)